CFAP119: Potential Drug Target and Biomarker (G90835)

Target Name: CFAP119

NCBI ID: G90835

CFAP119

CFAP119: Potential Drug Target and Biomarker

CFAP119 (CFAP119 variant 1) is a protein that is expressed in the connective tissue of the skin, heart, and kidneys. It is a member of the families of cytoskeletal proteins, which are involved in the structure and function of cells. There are several different variants of the CFAP119 gene, each of which has been shown to have different effects on the body.

One of the most interesting variants of CFAP119 is the variant that is targeted by drugs called small molecule inhibitors. These drugs work by binding to specific regions of the CFAP119 protein and interfering with its function. By blocking the activity of CFAP119, these drugs can be used to treat a variety of conditions, including cancer, neurodegenerative diseases, and skin diseases.

In addition to its potential as a drug target, CFAP119 is also a potential biomarker for some diseases. Because it is expressed in a variety of tissues throughout the body, it may be a useful indicator of disease, particularly in cases where the disease is caused by a loss of normal cell function. For example, low levels of CFAP119 have been observed in the skin, heart, and kidneys of people with a variety of conditions, including cancer and neurodegenerative diseases.

CFAP119 has also been shown to play a role in the development and progression of certain diseases. For example, studies have shown that high levels of CFAP119 are associated with an increased risk of developing skin cancer. Additionally, research has suggested that CFAP119 may be involved in the development of certain neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Despite the potential benefits of CFAP119 as a drug target and biomarker, much more research is needed to fully understand its role in the body. There are currently no approved drugs that are specifically designed to target CFAP119, and more research is needed to determine the best way to use this protein in clinical trials.

In conclusion, CFAP119 is a protein that is expressed in a variety of tissues throughout the body and is known for its role in the structure and function of cells. The variant that is targeted by small molecule inhibitors has the potential to be a valuable drug target and biomarker for a variety of conditions. Further research is needed to fully understand the role of CFAP119 in the body and its potential as a therapeutic agent.

Protein Name: Cilia And Flagella Associated Protein 119

The "CFAP119 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CFAP119 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets